Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Meditation may ease life with tough epilepsy

NCT ID NCT04687904

Symptom relief Sponsor: Rennes University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether mindfulness meditation training can improve quality of life and brain activity in people with refractory epilepsy (seizures that don't respond to drugs). 37 participants (patients and healthy volunteers) took part in meditation sessions. The main goal was to see if quality-of-life scores changed after 3 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mindfulness meditation training
What this could lead to
If it works, this could offer a drug-free way to improve quality of life for people with hard-to-treat epilepsy.
What could go wrong
This is a small, completed study with only 37 participants, so results may not apply to everyone. It focuses on quality of life, not seizure reduction, and meditation may not help all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

37 people

The number who actually took part.

Started

Jan 2021

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * For patients : * Patients over 16 years of age; * Epilepsy refractory to drug treatment according to the consensus criteria of the International League Against Epilepsy ; * Affiliated with a health insurance plan; * Free, informed and written consent signed by the patient, and parents for patients under the age of 18. * For healthy subjects : * Healthy subjects 16 years of age and older; * Affiliated with a health insurance plan; * Free, informed and written consent signed by the volunteer, or parents, for volunteers under the age of 18. Exclusion Criteria: * For patients : * Alcohol Addiction Disorders (assessed by the Mini-International Neuropsychiatric Interview (MINI) scale) ; * Patients with psychogenic crises; * Treatment with antidepressants; * Simultaneous participation in other research that may interfere with the protocol; * Persons of legal age subject to legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty. * For healthy subjects : * Psychiatric pathology and/or alcohol addiction disorders (evaluated by the MINI scale) ; * Simultaneous participation in other research that may interfere with the protocol; * Persons of legal age subject to legal protection (protection of justice, guardianship, trusteeship), persons deprived of liberty.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Epilepsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Epilepsy Healthy subjects

Contacts and locations

Locations

  • Centre Hospitalier Universitaire

    Rennes, 35033, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.